- Taking stock: second peak conquered
- Smaller companies share their experiences on REACH registration
- Ensure technical equivalence before applying for an EU or national authorisation for a biocidal product
- Are you importing or exporting hazardous chemicals?
- ENES5: Focus on mixtures
- How to find information about chemicals on ECHA's website
- First substance evaluation decisions to be finalised
- Lost in translation? Go to ECHA-term
- ECHA Science: Evaluation of grouping and read-across
- Wanted: practical examples from industry
- Member States agree on the practical actions of the SVHC Roadmap 2020
- Brazil interested in learning from ECHA's experiences
Send your feedback to:echanewsletter (at) echa.europa.eu
Article related to: News from ECHA
First substance evaluation decisions to be finalised
Member States have prepared proposals for first decisions on substance evaluation. Substance evaluation decisions, if prepared and endorsed, always request more information on the substance from the registrants. After unanimous agreement of the Member State Committee in November, ECHA will finalise the first batch of decisions for seven substances. They will be published on ECHA's website in 2014.
- First MSC agreements on substance evaluation, Press release 14 November 2013
- Draft update of substance evaluation planning for 2014-2016, News alert 4 November 2013
|Table on substances for which decisions are to be finalised. Once the decisions have been published, they can be accessed online through the CoRAP table by clicking on ‘Details'.|
Conclusion documents published on four evaluation cases
Did you know?
Member States are in charge of conducting substance evaluations.
After evaluating, they make a proposal to request further information from the registrants of a substance if the available information does not fully address the potential risks.
ECHA coordinates and supports the work of Member States. After consulting the registrants and all Member States, ECHA takes the final decision on substance.
In the case of non-unanimous agreement among the Member States, the Commission takes the final decision.
For follow up regulatory risk management measures, separate actions have to be initiated and the registrants will have the right to be heard on the measures.
Texts by Tiiu Bräutigam
Top image: Fotolia
Sign in to comment and/or rate this article.
Biocidal Products Committee:
26 February-1 March
Committee for Risk Assessment:
6-8 March and
Committee for Socio-Economic
Management Board meeting:
23-27 March (tentative)
Member State Committee:
20-24 April (tentative)